• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Circulating Tumor DNA as a Potential Emerging Biomarker in Malignant Phyllodes Tumors.

作者信息

Rosenberger Laura H, Reason Ellery H, Grilley-Olson Juneko E

机构信息

Duke University School of Medicine, Duke Cancer Institute, Durham, USA.

Duke University School of Medicine, Durham, USA.

出版信息

Ann Surg Oncol. 2025 Aug 5. doi: 10.1245/s10434-025-18015-z.

DOI:10.1245/s10434-025-18015-z
PMID:40762773
Abstract
摘要

相似文献

1
ASO Author Reflections: Circulating Tumor DNA as a Potential Emerging Biomarker in Malignant Phyllodes Tumors.ASO作者反思：循环肿瘤DNA作为恶性叶状肿瘤中一种潜在的新兴生物标志物
Ann Surg Oncol. 2025 Aug 5. doi: 10.1245/s10434-025-18015-z.
2
From Fibroadenoma to Phyllodes Tumor: Case Analysis of Borderline and Giant Breast Tumors with Literature Review.从纤维腺瘤到叶状肿瘤：交界性和巨大乳腺肿瘤病例分析及文献综述
Acta Med Litu. 2025;32(1):190-205. doi: 10.15388/Amed.2025.32.1.4. Epub 2025 Feb 18.
3
ASO Author Reflections: Malignant/Borderline Phyllodes Tumors Without Uniformly Poor Histologic Features Have an Excellent Prognosis.ASO作者反思：组织学特征并非一致较差的恶性/交界性叶状肿瘤预后良好。
Ann Surg Oncol. 2019 Dec;26(Suppl 3):619-620. doi: 10.1245/s10434-019-07459-9. Epub 2019 May 20.
4
ASO Author Reflections: How Far Should We Go in Local Management for a Localized Malignant Phyllodes Tumor of the Breast?
Ann Surg Oncol. 2020 Jun;27(6):1828-1829. doi: 10.1245/s10434-020-08390-0. Epub 2020 Mar 23.
5
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study.循环肿瘤DNA（ctDNA）在转移性恶性叶状肿瘤患者中可被可靠检测：一项可行性研究
Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17851-3.
6
ASO Author Reflections: The Management of Benign Phyllodes Tumors.ASO作者反思：良性叶状肿瘤的管理
Ann Surg Oncol. 2023 Dec;30(13):8457-8458. doi: 10.1245/s10434-023-14239-z. Epub 2023 Aug 28.
7
ASO Author Reflections: Surgical Management of Phyllodes Tumors of the Breast.ASO作者反思：乳腺叶状肿瘤的外科治疗
Ann Surg Oncol. 2023 Mar;30(3):1710-1711. doi: 10.1245/s10434-022-12922-1. Epub 2022 Dec 3.
8
ASO Author Reflections: Intratumoral Lipopolysaccharide as a Novel Biomarker of the Tumor Microenvironment and Prognosis in Esophageal Squamous Cell Carcinoma.ASO作者反思：肿瘤内脂多糖作为食管鳞状细胞癌肿瘤微环境和预后的新型生物标志物
Ann Surg Oncol. 2025 Jul 18. doi: 10.1245/s10434-025-17919-0.
9
ASO Author Reflections: Local Recurrence Risk and Risk Factors of Breast Phyllodes Tumors.ASO作者反思：乳腺叶状肿瘤的局部复发风险及危险因素
Ann Surg Oncol. 2019 Dec;26(Suppl 3):637-638. doi: 10.1245/s10434-019-07434-4. Epub 2019 Jun 17.
10
ASO Author Reflections: Development of Canadian National Consensus Statements on Phyllodes Tumors of the Breast.ASO作者反思：加拿大关于乳腺叶状肿瘤的国家共识声明的制定
Ann Surg Oncol. 2023 Oct;30(11):6398-6399. doi: 10.1245/s10434-023-13919-0. Epub 2023 Jul 15.

本文引用的文献

1
Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.无论肿瘤亚型如何，新辅助化疗与化生性乳腺癌的总生存期改善无关。
Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17938-x.
2
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses.晚期乳腺叶状肿瘤的全身治疗：一项多机构欧洲回顾性病例系列分析。
Breast Cancer Res Treat. 2022 Apr;192(3):603-610. doi: 10.1007/s10549-022-06524-4. Epub 2022 Feb 12.
3
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.
循环肿瘤DNA分析可检测II期结肠癌患者的微小残留病并预测复发。
Sci Transl Med. 2016 Jul 6;8(346):346ra92. doi: 10.1126/scitranslmed.aaf6219.
4
Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast.乳腺叶状肿瘤远处转移患者的治疗
World J Surg. 2016 Feb;40(2):323-8. doi: 10.1007/s00268-015-3262-7.
5
Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.多柔比星联合达卡巴嗪的辅助化疗对乳腺恶性叶状肿瘤的无复发生存率没有影响。
Breast J. 2007 Nov-Dec;13(6):551-6. doi: 10.1111/j.1524-4741.2007.00510.x.